Endeavor

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

Moffitt Experts Conduct First Analysis on New Criteria for Chronic Myelomonocytic Leukemia

Study finds patients who were switched to a chronic myelomonocytic leukemia diagnosis based on the new criteria more so resembled myelodysplastic syndromes genetically.

Moffitt Patients Meet Donors at Transplant Reunion

This event celebrated survivorship and coincided with the 35th anniversary of Moffitt's Blood and Marrow Transplant and Cellular Immunotherapy Department

Molecular Risk Model Better Predicts Outcomes in Rare Blood Cancer

New model can help dictate treatment decisions in chronic myelomonocytic leukemia